Ultragenyx: Ready For More Growth After Q3 Earnings Beat
Ultragenyx Pharmaceutical(RARE) Seeking Alpha·2024-11-13 00:12
Thank you for reading my research on Seeking Alpha. If you want to learn even more about my method and how I discover these investment opportunities, please check out my subscription marketplace service, Compounding Healthcare , and sign up for a free trial.It has been years since I have considered restarting a position in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ) after having a string of big wins in gene therapy tickers following Biogen Inc.'s ( BIIB )He is the leader of the investing group Compoundin ...